Cannabis and Hemp Industry Investment News
's () Sean Hall tells Proactive that the company is building a cannabis-based drug that is the size of a nanoparticle. Hall adds that the company is c...
The licence opens up potential international markets for its cannabis-based medicines. The two cannabis-based medicines are NanaBis™ and NanaBidial™ (...
NanoCelle™ is a mouth spray delivery system targeting cannabis-based medicines. Research is being conducted by University of Sydney’s Nano Institute (...
Three studies are the focus as the company targets chronic illnesses, including cancer, using a pipeline that includes cannabis products and probiotic...
() CEO & managing director Dr. Sean Hall tells Proactive Investors, "probably one of the biggest things in medicine to date" is research into the ...
Focus of trial on safety and tolerability for oncology patients undergoing chemotherapy. Trial is for mucositis which affects +40% of chemotherapy pat...
Sydney-based investor has increased its interest to 10.51% through on-market purchases and placement participation. Medlab is focused on deliveries th...
() CEO & managing director Dr. Sean Hall speaks with Proactive Investors about the biotech's various research and development programs, focused on...
Medlab has already developed two cannabis-based medicines, NanaBis™ and NanaBidial™. NanaBis™ will be administered by medicine delivery platform, Nano...
The trial is designed to meet the Therapeutic Goods Administration's requirements for expedited drug approval. Annual cost of mental illness in Austra...
Medlab has approval to supply NanaBis™ under the TGA's Special Access Scheme. Earlier this year, the company raised $24 million in a placement () is o...
The trial will test the safety, efficacy and dose tolerance in cancer patients. Medlab is developing medicines for pain management Ltd () has commence...
Medlab developed the nanoparticle medicine delivery system, Nanocelle. On validation of the manufactured product, Medlab will be in a position to supp...
NanaBis is a mouth spray and will be clinically tested in advanced stage cancer patients. New funds are expected to help accelerate commercialisation ...
DehydraTECH turns cannabis and hemp oils into stabilized powders, which allows for faster absorption Lexaria sells its pre-processed CBD/hemp DehydraT...
The company is developing cannabis-based medicines like NanaBis™ for pain management and is focussed on securing a pathway to drug registration and ma...
The agreement results in manufacturing of the patented cannabis-based medicine being transferred to Tasmanian Alkaloids. NanaBis is poised for a major...
Medlab is a revenue generating research company with an aggressive product development pipeline. The number of NanaBis™ and NanaBidial™ cannabis bottl...
What does Medlab Clinical do? () is a cannabis drug developer and nutraceutical products manufacturer based in Australia. The seven-year-old New South...
Placement funds will help the company address short-term goals as it prepares for Phase 3 research of the NanaBis™ drug candidate program. The placeme...
